JPRN-UMIN000019855招募中未知
A study to Determine Enzalutamide Long-term safety and efficacy after anti-androgen therapy for CRPC. - A study to Determine Enzalutamide Long-term safety and efficacy after anti-androgen therapy for CRPC. (DELC study)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1)Patients who is administering or have administration history of enzalutamide, abiraterone, docetaxel or cabazitaxel 2)Patients with history of seizure or predisposing disease of seizure 3)Patients with severe liver dysfunction 4)Patients with a previous history of hypersensitivity to any component of drugs which will be administered in this study 5)Patients who considered to be inappropriate for the study participation by the investigator
研究者
相似试验
已完成
不适用
A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPCCastration Resistant Prostate Cancer (CRPC)NCT02669147Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan160
已完成
不适用
Investigation of clinical efficacy of Enzalutamide and its predictive factors in CRPC patientscastration resistant prostate cancerJPRN-UMIN000015996Keio University School of Medicine50
已完成
2 期
Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast CancerAdvanced, Androgen Receptor Positive Triple Negative Breast CancerNCT01889238Pfizer118
已完成
4 期
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer PatientsProstate CancerNCT01995513Pfizer509
尚未招募
2 期
The efficacy and safety of enzalutamide in patients with non-muscle invasive bladder cancernon-muscle invasive bladder cancerJPRN-UMIN000026520rology department of Tsukuba University Hospital10